Ilika Plc Manufacturing agreement for Stereax® with Semefab Ltd

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery technology and materials innovation company, announced today an intended manufacturing partnership with Semefab Ltd for the manufacture of Stereaxâ thin film solid-state cells.

Since 1986, Semefab has produced a diverse portfolio of CMOS, ASIC and semiconductor technologies. Ilika and Semefab have undertaken a detailed review of Ilika’s qualified process for the manufacture of Stereaxâ thin film batteries. Semefab has confirmed that it has the microfabrication know-how to be able to manufacture Stereaxâ cells on an economic basis in quantities suitable for market introduction of products. Semefab has also confirmed that the Ilika process is technically compatible with its facility in Fife, Scotland.

Allan James, Semefab Managing Director, stated: “We believe there is a substantial market opportunity for thin-film microfabricated batteries, which is well-aligned with our current business.”

Graeme Purdy, Ilika plc CEO added: “We are delighted to be working with Semefab, which has a long history of manufacturing MEMS and IC products. Semefab is arguably currently the UK’s leading commercial foundry of such devices. This key manufacturing partnership extends Ilika’s market reach and advances the Company one step closer to a valuable licensing deal.”

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Solid state design drives weight, cost and efficiency gains

Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.

Ilika aligns solid state production with lithium-ion supply chains

Ilika’s Goliath batteries are being scaled with standard lithium-ion tools and low-cost materials to match today’s battery economics.

Search

Search